Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
S Korea to buy 10 million doses of SK Bioscience’s COVID vaccine
The South Korean company has since August conducted phase-III trials of its vaccine candidate, codenamed "GBP510," jointly…
Dr Mansukh Mandaviya launches BRICS vaccine R&D centre
BRICS vaccine R&D centre is a welcome initiative to collaborate with countries, share experiences, build collaborations for…
Indoco Remedies gets final nod from US FDA for Lacosamide tablet
The approval granted by the US Food and Drug Administration (FDA) for Lacosamide tablets is for strengths of 50 mg, 100 mg, 150 mg…
Pfizer recalls some lots of blood pressure drug due to potential carcinogen
Pfizer said it has not received any reports of adverse events related to the drug till date
Hester Biosciences ventures into pet care industry
India has the fastest-growing pet care market worldwide, with it growing by 14 per cent in 2022
Novartis suspends some business activities in Russia
The move by Novartis follows similar steps by other drugmakers following sanctions against Moscow for its invasion of Ukraine
Parliamentary panel for framing price control regime for COVID medicines medical devices
The panel also recommended exemption of basic customs duty and GST on medicines and medical devices for fighting COVID-19
Evotec receives €3 million payment for Bayer starting phase-II clinical development of DNP programme
The phase-II study is anticipated to run until the end of 2022
Sun Pharma to acquire 11.28 per cent stake in Zenotech from Daiichi Sankyo
Sun Pharma said it will pay Rs 5.32 crores for the stake
Pfizer’s antiviral COVID drug still effective despite resistance fear
Researchers from the Rutgers University in the US showed that the Pfizer antiviral drug Paxlovid still quashes COVID by jamming…